GENE ONLINE|News &
Opinion
Blog

2018-03-07|

7 March, 1938: American biologist David Baltimore was born

by GeneOnline
Share To

American biologist David Baltimore (7 March, 1938 – present) is currently the President Emeritus and Robert Andrews Millikan Professor of Biology. After Renato Dulbecco discovered that tumor viruses operate by incorporating their DNA into the DNA of host cells, David Baltimore and Howard Temin – independently of one another – discovered that viruses with genomes consisting of RNA can also be inserted into host cells’ DNA. This takes place through an enzyme known as “reverse transcriptase”. The discovery that the information in RNA can be transferred to DNA meant that the generally accepted rule that genetic information was only transferred in one direction – from DNA to RNA, to protein – had to be modified. This finding led them to the Nobel Prize in Physiology or Medicine in 1975. David Baltimore was only 37 that year.

Reference
https://www.bbe.caltech.edu/content/david-baltimore

Image Source
https://commons.wikimedia.org/wiki/File:Dr._David_Baltimore1.jpg#file

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
Bacteriophage Characteristics Could Provide the Key to Tackling Viruses
2022-11-02
Svante Pääbo Wins Physiology or Medicine Nobel Prize for Human Evolution Discoveries
2022-10-06
Three Scientists Jointly Win Nobel Prize for Innovations in Click Chemistry
2022-10-06
LATEST
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
3D Printed Brain Model Could Aid in Neurosurgery
2023-03-31
Latest Study on Neuronal Gene Expression May Shed Light on the Memory Formation Process
2023-03-30
Emergent BioSolutions’ Over-The-Counter Naloxone Nasal Spray Receives FDA Greenlight
2023-03-30
Current Trends of iPSC Manufacturing and Clinical Applications – An Interview with Professor Xianmin Zeng
2023-03-29
U.S.-German Joint Discovery May Spark Breakthrough in Diabetes Research
2023-03-29
Merck Regains Worldwide Rights to BAVENCIO After Parting Ways with Pfizer
2023-03-29
Scroll to Top